Insider Trading: Isis Pharmaceuticals Inc (ISIS.O)
ISIS.O on Nasdaq
20.66USD
17 May 2013
20.66USD
17 May 2013
Price Change (% chg)
$0.50 (+2.48%)
$0.50 (+2.48%)
Prev Close
$20.16
$20.16
Open
$20.30
$20.30
Day's High
$20.75
$20.75
Day's Low
$20.07
$20.07
Volume
1,729,851
1,729,851
Avg. Vol
1,619,117
1,619,117
52-wk High
$23.03
$23.03
52-wk Low
$7.55
$7.55
| GEARY RICHARD S | Options Exercised: 0 | ||
| Trade Date: | Sunday, 8 Jul 2012 | Price: | 13.45 |
| Title: | Officer | Shares Held: | 3,190 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 0 |
Institutional Holders
| % Shares Owned: | 78.31% |
| # of Holders: | 213 |
| Total Shares Held: | 87,467,751 |
| 3 Mo. Net Change: | 6,527,321 |
| # New Positions: | 51 |
| # Closed Positions: | 19 |
| # Increased Positions: | 100 |
| # Reduced Positions: | 84 |
| # Net Buyers: | 16 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Stanley Crooke |
67 | 1991 | Chairman of the Board, President, Chief Executive Officer |
Elizabeth Hougen |
51 | 2013 | Chief Financial Officer, Senior Vice President - Finance |
B. Lynne Parshall |
58 | 2013 | Chief Operating Officer, Corporate Secretary, Director |
Patrick O'Neil |
39 | 2013 | Senior Vice President - Legal, General Counsel |
C. Frank Bennett |
56 | 2006 | Senior Vice President - Antisense Research |
Richard Geary |
55 | 2008 | Senior Vice President - Development |
Brett Monia |
51 | 2012 | Senior Vice President - Drug Discovery and Corporate Development |
Spencer Berthelsen |
60 | 2002 | Independent Director |
Joseph Klein |
51 | 2005 | Independent Director |
Frederick Muto |
2001 | Independent Director | |
Joseph Wender |
67 | 1994 | Independent Director |
Wade Walke |
Executive Director - Corporate Communications |

